Lisdexamfetamine Dimesylate 70010-0208-01
- Manufacturer
- Granules Pharmaceuticals Inc.
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- January 29, 2025
- Listing Expires
- December 31, 2027
- Application
- ANDA218987
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lisdexamfetamine Dimesylate | 30 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Selected Package
70010-0208-01Selected100 CAPSULE in 1 BOTTLE (70010-208-01)